Written answers
Tuesday, 28 November 2017
Department of Health
Medicinal Products Reimbursement
Billy Kelleher (Cork North Central, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
323. To ask the Minister for Health the outcome of the meeting between a company (details supplied) and the HSE in recent days regarding the drug Vimizim for the treatment of Morquio disease; and if he will make a statement on the matter. [49906/17]
Kathleen Funchion (Carlow-Kilkenny, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
398. To ask the Minister for Health if the HSE drugs committee group met on 14 September 2017; if the drug Vimizim was discussed; if a decision was made to reimburse the drug; and if he will make a statement on the matter. [50276/17]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
I propose to take Questions Nos. 323 and 398 together.
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
No comments